Theravance Biopharma, Inc. (TBPH)

United States Steel Revenue

Theravance Biopharma had revenue of $15.39M in the quarter ending March 31, 2025, with 6.10% growth. This brings the company's revenue in the last twelve months to $65.27M, up 6.11% year-over-year. In the year 2024, Theravance Biopharma had annual revenue of $64.38M with 12.12% growth.

• Revenue (ttm): $65.27M
• Revenue Growth: +6.11%
• P/S Ratio: 8.22
• Revenue / Employee: $672,845
• Employees: 97
• Market Cap: 545.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	64.38M	6.96M	12.12%
Dec 31, 2023	57.42M	6.08M	11.84%
Dec 31, 2022	51.35M	-3.97M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.